论文部分内容阅读
长期家庭氧疗(LTOT)能改善伴有低氧血症的慢性阻塞性肺疾病(COPD)患者的生存和生活质量,但达到接受LTOT条件的COPD已属晚期,往往同时需要定期的药物治疗。本文作者对1987年1月1日至1989年6月30日在瑞典国家氧疗机构注册接受LTOT的403例COPD患者进行了包括氧疗在内的药物治疗。对性别、全身状况与住院和病死率之间关系的前瞻性研究。 结果 403例患者中,男201例,女202例,女性患者年龄(66±8岁)小于男性患者年龄(68±9岁,P<
Long-term home oxygen therapy (LTOT) improves the quality of life and quality of life in patients with chronic obstructive pulmonary disease (COPD) associated with hypoxemia, but reaching the stage of exacerbation of LTOT is often accompanied by the need for regular medical treatment. The authors performed pharmacologic interventions, including oxygen therapy, on 403 COPD patients enrolled in the Swedish National Oxygen Facility from January 1, 1987 to June 30, 1989, who received LTOT. Prospective study of the relationship between gender, general condition and hospitalization and case fatality rates. Results Of the 403 patients, 201 were male and 202 were female. The female patient’s age (66 ± 8 years) was less than the male patient’s age (68 ± 9 years, P <